Article ISI SCOPUS
EXPERT OPINION ON INVESTIGATIONAL DRUGS  (2019)

Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease

Camins, A; Ettcheto, M; Busquets, O; Manzine, PR; Castro-Torres, RD; Beas-Zarate, C; Verdaguer, E; Sureda, FX; Bullo, M; Olloquequi, J; Auladell, C; Folch, J

Keywords: alzheimer's disease, glucagon, type 2 diabetes, glucose-dependent insulinotropic peptide, glucagon-like peptide

Más información

Título según WOS: Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease
Título según SCOPUS: Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
Título de la Revista: EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volumen: 28
Número: 1
Editorial: TAYLOR & FRANCIS LTD
Fecha de publicación: 2019
Página de inicio: 93
Página final: 97
Idioma: English
DOI:

10.1080/13543784.2019.1552677
Notas: ISI, SCOPUS